K-numberK251358
Device nameBridge Plus Occlusion Balloon (590-002)
ApplicantPhilips Image Guided Therapy Devices
Product codeMJN
Device classClass II
Decision dateJun 24, 2025
DecisionSubstantially Equivalent
Regulation870.4450
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Bridge Plus Occlusion Balloon is a catheter designed for temporary vessel occlusion of the superior and inferior vena cava. It is used for perioperative occlusion and emergency control of hemorrhage during vascular procedures. The device consists of a compliant polyurethane balloon mounted on a 12Fr dual-lumen nylon shaft with an 80mm balloon length and inflation diameter of 20-29mm.

Technological characteristics

The Bridge Plus Occlusion Balloon is similar in design and performance to predicate devices but differs in materials of construction and balloon/catheter design. Like the predicates, it is deliverable to target vasculature and appropriately sized for vascular occlusion. The subject device includes vessel specificity for both SVC and IVC in its indication, whereas the predicates do not specify this dual-vessel use.

Test standards cited

ISO 11135:2014 Amendment 1 was used for sterilization validation, including bioburden resistance studies and bioburden method validation. Biocompatibility testing followed standards covering cytotoxicity, sensitization, irritation, pyrogenicity, hemolysis, thromboplastin time, platelet/leukocyte counts, surface analysis, and complement activation.

Substantial equivalence argument

The Bridge Plus Occlusion Balloon demonstrates substantial equivalence through design similarities and performance parity with both the QX Medical Occlusion Balloon Catheter and Bridge Occlusion Balloon Catheter predicates. Although materials and design details differ, comprehensive performance testing—including dimensional, deployment, inflation/deflation, vessel occlusion, fatigue, and biocompatibility assays—confirmed the device meets all specifications and performs comparably to predicates. No new preclinical or clinical data were required, as design similarities and test data adequately supported equivalence.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →